In two clinical trials, Evrysdi improved motor function in people living with SMA over a broad spectrum of ages and levels of disease severity, including Types 1, 2, and 3 SMA
Labs and art studios will be among the first courses to take place in person, while other classes will begin online on Aug. 24.
Continue reading
The BIOEquality Agenda is a national effort in collaboration with our partners and member organizations in the biotechnology sector that aims to counteract the systemic inequality, injustice, and unfair treatment of underserved communities. Continue reading
The Center for Applied NanoBioscience and Medicine Awarded Grant from NASA to Develop Prototype by September 2020
Amid the coronavirus pandemic, a team of researchers at the University of Arizona College of Medicine – Phoenix are developing a device that will easily and accurately detect COVID-19 in a matter of minutes.Continue reading
Company working to ensure broad global access to COVID-19 vaccine candidate, following approval from regulatorsContinue reading
ASU’s chief science and technology officer will lead the nonprofit, which connects researchers, businessesContinue reading
AdvaMed’s National Testing Registry: Shipments of COVID-19 Molecular Diagnostic Tests Reach 100 MillionContinue reading
The global pandemic caused by the novel coronavirus has affected nearly every aspect of daily life in Arizona and across the nation, putting many summer activities on pause in the midst of great uncertainly. But as ASU advances an ambitious agenda designed to keep the Sun Devil community safe this coming academic year, research at the Biodesign Institute marches forward.Continue reading
Integrated protein and metabolite analysis open the door to more precise ways of guiding treatment for the nearly 70 million people worldwide who annually suffer traumatic brain injuriesContinue reading